Eupraxia Pharmaceuticals EPRX Ratios (2022-2026)

NASDAQ EPRX
$8.31 +0.10 (+1.16%)
At close: Sep 29, 2026 · 4:00 PM EDT
Reported Financials

Eupraxia Pharmaceuticals Quarterly Ratios

Periods 14 quarters
Latest Jun 2026

Eupraxia Pharmaceuticals ratios data for the quarter ended Jun 2026. These financial ratios cover 14 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Dec2022 Mar2023 Jun2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Efficiency
Assets AverageAssets Avg. 28.45M30.81M17.67M22.65M32.09M26.41M57.97M89.25M115.75M142.63M
Equity AverageEquity Avg. 9.50M15.72M10.66M19.91M29.44M24.01M54.71M84.44M108.32M132.93M
Invested CapitalInvested Cap. 7.35M0.96M18.15M13.36M31.84M
Leverage & Solvency
Interest Coverage RatioInterest Cover -14.57-32.50-20.16-22.53-0.01M-0.05M
Debt Ratio 0.010.000.000.00
Times Interest Earned -14.57-32.50-20.16-22.53-0.01M-0.05M
Valuation
Price to BookP/B 5.288.993.554.329.792.383.752.122.04
Enterprise Value 45.58M61.55M78.32M87.88M183.95M119.74M219.51M148.81M128.85M
Market Capitalization 70.39M71.75M112.98M116.90M205.30M210.29M301.67M289.28M264.11M
Return Ratios
Return on Capital Employed [ROCE]ROCE -139.98%-187.12%-134.76%-89.13%-121.99%-54.30%-46.14%-41.02%-37.43%
Return on Assets [ROA]ROA -109.36%-90.36%-163.54%-120.06%-86.45%-109.44%-51.61%-40.88%-38.75%-38.19%
Return on Equity [ROE]ROE -327.53%-177.05%-271.14%-136.62%-94.23%-120.42%-54.68%-43.21%-41.41%-40.97%

Eupraxia Pharmaceuticals Ratios API

Pull Eupraxia Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=EPRX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY